Hear about the latest advances and future challenges in the development of efficacious cell-based therapies with learnings from the first allogeneic stem cell-based therapy approved by the European Medicines Agency for treatment of complex perianal fistulas in Crohn’s disease, mechanisms and results from several trials using CD34+ cell therapy for treatment of cardiovascular disease, and results of pre-clinical and IND enabling studies of MSC-based therapies for treating pediatric patients with cerebral palsy and autism. Read more about Plenary Session 6.